Rezension:

I really like swimming rocket tube Lixisenatide is approved for use in several countries, including Mexico, Japan, Australia, and across Europe, for treating Type 2 diabetes in adults, the company said. However, Sanofi's NDA for lixisenatide included early data on its ELIXA cardiovascular outcomes study, and there are concerns from the company that if early results of the study were to become public, it could compromise the ongoing study's integrity.

Bewertung: